S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
MarketBeat Week in Review – 3/20 - 3/24
Fed's Shocking New Plan to Control Your Money (Ad)
Bank failures and rescue test Yellen's decades of experience
Germany, EU reach agreement in combustion engine row
Fed's Shocking New Plan to Control Your Money (Ad)
Intel co-founder, philanthropist Gordon Moore dies at 94
'What can we do?': Millions in African countries need power
BREAKING: Tiny biotech successfully treats blindness (Ad)
Judge rules online archive's book service violated copyright
Renamed Horseshoe to host Poker World Series on Vegas Strip
S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
MarketBeat Week in Review – 3/20 - 3/24
Fed's Shocking New Plan to Control Your Money (Ad)
Bank failures and rescue test Yellen's decades of experience
Germany, EU reach agreement in combustion engine row
Fed's Shocking New Plan to Control Your Money (Ad)
Intel co-founder, philanthropist Gordon Moore dies at 94
'What can we do?': Millions in African countries need power
BREAKING: Tiny biotech successfully treats blindness (Ad)
Judge rules online archive's book service violated copyright
Renamed Horseshoe to host Poker World Series on Vegas Strip
S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
MarketBeat Week in Review – 3/20 - 3/24
Fed's Shocking New Plan to Control Your Money (Ad)
Bank failures and rescue test Yellen's decades of experience
Germany, EU reach agreement in combustion engine row
Fed's Shocking New Plan to Control Your Money (Ad)
Intel co-founder, philanthropist Gordon Moore dies at 94
'What can we do?': Millions in African countries need power
BREAKING: Tiny biotech successfully treats blindness (Ad)
Judge rules online archive's book service violated copyright
Renamed Horseshoe to host Poker World Series on Vegas Strip
S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
MarketBeat Week in Review – 3/20 - 3/24
Fed's Shocking New Plan to Control Your Money (Ad)
Bank failures and rescue test Yellen's decades of experience
Germany, EU reach agreement in combustion engine row
Fed's Shocking New Plan to Control Your Money (Ad)
Intel co-founder, philanthropist Gordon Moore dies at 94
'What can we do?': Millions in African countries need power
BREAKING: Tiny biotech successfully treats blindness (Ad)
Judge rules online archive's book service violated copyright
Renamed Horseshoe to host Poker World Series on Vegas Strip
NASDAQ:FNJN

Finjan - FNJN Stock Forecast, Price & News

Notice: This company has been marked as potentially delisted and may not be actively trading.
Add
Compare
Today's Range
$1.54
$1.54
50-Day Range
$1.54
$1.54
52-Week Range
$0.75
$2.39
Volume
N/A
Average Volume
145,068 shs
Market Capitalization
$42.66 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

FNJN stock logo

About Finjan (NASDAQ:FNJN) Stock

Finjan Holdings, Inc., a cybersecurity company, provides intellectual property licensing and enforcement services in the United States and internationally. The company owns a portfolio of patents related to software and hardware technologies that proactively detect malicious code and thereby protects end users from identity and data theft, spyware, malware, phishing, Trojans, and other Web and network threats. Its patented technologies are used in specific cybersecurity technology areas, including endpoint/cloud software, Web gateway/Internet infrastructure, networking equipment markets, and mobile security. The company's technology scans and repels the latest and unknown threats to network, Web, and endpoint devices on a real-time basis. It also develops mobile security applications; and invests in cybersecurity technologies and intellectual property. Finjan Holdings, Inc. was founded in 1997 and is headquartered in East Palo Alto, California.

Receive FNJN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Finjan and its competitors with MarketBeat's FREE daily newsletter.

FNJN Stock News Headlines

BREAKING: Tiny biotech successfully treats blindness
There's a tiny biotech in Cambridge that's using a breakthrough technology to treat blindness. This company has already shown success in human trials... And Our research shows that anyone who gets in today could see a 46,751% return.
Fed's Shocking New Plan to Control Your Money
The Federal Reserve has a disturbing plan that is getting ready to roll out as soon as May. This is a lot more than printing trillions of dollars or manipulating interest rates. It's about every checking account, every purchase and every money transfer in America — including yours and mine. 
See More Headlines
Receive FNJN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Finjan and its competitors with MarketBeat's FREE daily newsletter.

FNJN Company Calendar

Last Earnings
5/13/2020
Today
3/25/2023

Industry, Sector and Symbol

Industry
Patent Owners & Lessors
Sub-Industry
N/A
Current Symbol
NASDAQ:FNJN
Fax
N/A
Employees
10
Year Founded
N/A

Profitability

Net Income
$-16,490,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$13.15 million
Book Value
$1.42 per share

Miscellaneous

Free Float
N/A
Market Cap
$42.66 million
Optionable
Optionable
Beta
0.95

Key Executives

  • Mr. Philip Hartstein (Age 43)
    Pres & CEO
  • Mr. Michael D. Noonan (Age 60)
    CFO, Treasurer & Sec.
  • Ms. Julie Mar-Spinola (Age 62)
    Chief Intellectual Property Officer & VP of Legal Operations
  • Ms. Vanessa Winter
    Director of Investor Relations & Corp. Communications
  • Ms. Rebecca Galdos
    Mang. of Office & HR













FNJN Stock - Frequently Asked Questions

How were Finjan's earnings last quarter?

Finjan Holdings, Inc. (NASDAQ:FNJN) posted its earnings results on Wednesday, May, 13th. The software maker reported ($0.15) EPS for the quarter, meeting analysts' consensus estimates of ($0.15). The software maker had revenue of $3.80 million for the quarter, compared to analysts' expectations of $3.80 million.

What other stocks do shareholders of Finjan own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Finjan investors own include OPKO Health (OPK), DURECT (DRRX), (HCLP) (HCLP), Stage Stores (SSI), Energous (WATT), Advanced Micro Devices (AMD), Corus Entertainment (CJREF), Checkpoint Therapeutics (CKPT), AT&T (T) and Applied Materials (AMAT).

What is Finjan's stock symbol?

Finjan trades on the NASDAQ under the ticker symbol "FNJN."

What is Finjan's stock price today?

One share of FNJN stock can currently be purchased for approximately $1.54.

How much money does Finjan make?

Finjan (NASDAQ:FNJN) has a market capitalization of $42.66 million and generates $13.15 million in revenue each year. The software maker earns $-16,490,000.00 in net income (profit) each year or ($0.60) on an earnings per share basis.

How can I contact Finjan?

Finjan's mailing address is 2000 UNIVERSITY AVENUE SUITE 600, EAST PALO ALTO CA, 94303. The official website for the company is www.finjan.com. The software maker can be reached via phone at 650-282-3228 or via email at investors@finjan.com.

This page (NASDAQ:FNJN) was last updated on 3/25/2023 by MarketBeat.com Staff